glucagon dual
- Health
Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH
Copenhagen, Denmark & Ingelheim, Germany: FDA’s Fast Track Designation for the GLP-1/glucagon dual agonist underscores the urgent need for new…
Read More »